Biofrontera reports Q1 2020 financial results
May 19, 2020 10:15 ET
|
Biofrontera AG
Leverkusen, May 19, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial...
Biofrontera dismisses case against DUSA Pharmaceuticals, Inc. in California state court
May 13, 2020 04:00 ET
|
Biofrontera AG
Leverkusen, Germany, May 13, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or “Biofrontera”), an international biopharmaceutical company, today...
Biofrontera announces conference call to be held on May 20, 2020 to discuss first quarter 2020 financial results
May 12, 2020 11:00 ET
|
Biofrontera AG
Leverkusen, Germany, May 12, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Biofrontera Reports Full Year 2019 Financial Results
April 20, 2020 11:06 ET
|
Biofrontera AG
Leverkusen, Germany, April 20, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd.
April 20, 2020 04:20 ET
|
Biofrontera AG
Leverkusen, Germany, April 20, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, has...
Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020
April 17, 2020 05:15 ET
|
Biofrontera AG
Leverkusen, Germany, April 17, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Biofrontera AG to propose resolution for ordinary capital increase to the Annual General Meeting
April 16, 2020 10:00 ET
|
Biofrontera AG
Leverkusen, Germany, April 16, 2020 (GLOBE NEWSWIRE) -- The Annual General Meeting of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) shall be held on May 28, 2020. Today, the Company...
Biofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial results
April 09, 2020 12:30 ET
|
Biofrontera AG
Leverkusen, Germany, April 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
Biofrontera AG withdraws subscription offers for mandatory convertible bonds
March 23, 2020 10:45 ET
|
Biofrontera AG
Leverkusen, Germany, March 23, 2020 (GLOBE NEWSWIRE) -- On February 26, 2020, the Management Board resolved to issue up to 1,600,000 of the 0.5% qualified subordinated mandatory convertible bonds...
Biofrontera implements comprehensive measures to reduce costs during COVID-19 pandemic
March 20, 2020 04:15 ET
|
Biofrontera AG
Leverkusen, Germany, March 20, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...